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Introduction. Laparo-endoscopic single-site surgery (LESS) may diminish morbidity of laparoscopic surgery. We prospectively
evaluated feasibility and outcomes of LESS-Radical Nephrectomy (LESS-RN) and Partial Nephrectomy (LESS-PN). Methods.1 0
patients underwent LESS-RN (6) and LESS-PN (4) between 2/2009-5/2009. LESS-RN included 2 with renal vein thrombectomy,
one of which was also cytoreductive. Transperitoneal LESS access was obtained by periumbilical incision. Patient/tumor
characteristics, oncologic, and quality of life (QoL) outcomes were analyzed. Results. 3 Men/7 Women (mean age 58.7 years,
median follow-up 9.8 months) underwent LESS. 9/10 cases were completed successfully. All had negative margins. Mean operative
time was 161 minutes, estimated blood loss was 125 mL, and incision size was 4.4 cm. Median tumor size for LESS-RN and -PN
was 5.0 and 1.7 cm (P = .045). Median LESS-PN ischemia time was 24 minutes; mean preoperative/postoperative creatinine were
0.7/0.8 mg/dL (P = .19). Mean pain score at discharge was 1.3. Mean preoperative, 3-, and 6-month postoperative SF-36 QoL
Score was 73.8, 74.4 and 77.1 (P = .222). All patients are currently alive. Conclusions. LESS-RN, renal vein thrombectomy, and
PN are technically feasible and safe while maintaining adherence to oncologic principles, with excellent QoL preservation and low
discharge pain scores. Further study is requisite.
1.Introduction
Incidence of Renal Cell Carcinoma is increasing world wide.
In 2009, approximately 57,760 patients were diagnosed with
kidney cancer in the United States alone [1, 2]. Surgical
excision remains the mainstay of therapy for localized
disease and a cornerstone of care form appropriate patients
with advanced disease. Since introduction of laparoscopic
radical nephrectomy (LRN) the procedure has been reﬁned
and adopted as a standard of care for appropriate renal
masses, with advantages including decreased blood loss,
lower narcotic requirements, shorter hospital stays, and
more rapid return to normal activities while maintaining
equivalentshort-andlong-termoncologiceﬃcacycompared
with open radical nephrectomy [3–5]. These improved
outcomes are thought in large part to be a result of the
smaller incisions, and thus laparoscopy has rapidly emerged
asstandardofcareforradicalnephrectomy[6].Similartothe
introduction of LRN with its equivalent oncologic outcomes
andimprovedmorbidityproﬁle,withtheadventofimproved
laparoscopic surgical instrumentation and reﬁnements in
technique, LPN has emerged as a viable alternative to open
partial nephrectomy (OPN) with equivalent short- and
intermediate-term outcomes for selected patients [7, 8].
By combining working trocar sites and the eventual
extraction site into a single location, Laparo-endoscopic
single-site surgery (LESS) further limits the invasiveness of
laparoscopy and may enhance advantages associated with
traditional laparoscopy. Reduced incisional morbidity and
improved cosmesis have largely sparked a growing interest2 Diagnostic and Therapeutic Endoscopy
Figure 1: Representative image of a large (7×8cm right upper pole
mass) which underwent LESS-RN.
in utilization of this technique to perform upper tract
urologicsurgery[9–11].Concernsregardingtheapplicability
of LESS are signiﬁcant and center around the issues of
restricted freedom of movement resulting in instrument
clashing and lack of triangulation [9–11]. Herein we describe
our technique and our initial prospective evaluation of LESS
Radical Nephrectomy (LESS-RN) and Partial Nephrectomy
(LESS-PN) for excision of enhancing renal masses and
evaluate its short-term disease-based and quality of life
impact.
2. Methods
2.1. Patient Selection. Prospective single institutional evalua-
tionofLESSisperformedbyasinglesurgeon(IHD).Patients
werereferredwithrenalmasseswithradiographiccriteriafor
suspicious for malignancy (Figure 1). All patients underwent
complete history and physical exam and staging workup
(chest/abdominal/pelvic computed tomography, liver func-
tion tests, and bone scintigraphy if necessary). Exclusion
criteria for LESS included patients with imperative criteria
for partial nephrectomy (solitary kidney, bilateral tumors,
and preexisting nondialysis-dependent renal insuﬃciency),
and tumors which crossed the midline, or those with
bulky lymphadenopathy. Patients are considered for LESS-
PN if they had a renal mass that was deemed amenable
to laparoscopic partial nephrectomy (LPN). Patients were
considered for LESS-RN if they were not deemed to be
amenable to LPN and were candidates for elective OPN, but
stated an explicit preference for RN despite potential feasi-
bility of OPN. All procedures were consecutively performed
between 2/2009 and 6/2009. Patient demographic factors,
tumor characteristics, perioperative variables, outcomes and
complications,andqualityoflife(QoL)scoreswererecorded
at time of enrollment and analyzed.
Figure 2: LESS Platform, periumbilical incision for left radical
nephrectomy, demonstrating, in cranial to caudal direction (left to
right): 5mm Extralong Xcel Trocar, 5mm short nonshielded trocar,
a n d1 2m mX c e lT r o c a r .
2.2. Surgical Technique for LESS-RN. After general anes-
thesia, the patient is placed in a modiﬁed ﬂank position
(with the patient at a 30 degree angle with the kidney rest
up and the table ﬂexed). A 3-4cm periumbilical incision
is made and carried down to the anterior abdominal wall
fascia. A 5mm extralong (150mm length) Xcel trocar
(Ethicon-Endosurgery, Cincinnati, OH) is then inserted at
the most cranial aspect of this incision, at the junction of the
umbilicus with the fascia; pneumoperitoneum to 15mmHg
is obtained and a 5mm-zero degree 35cm-long laparoscope
(Strkyer, Kalamazoo, MI) is inserted to inspect the abdomen;
subsequently a 65mm-long, nonshielded low proﬁle (65mm
length) trocar (Ethicon) is inserted under direct vision at
a position 1.0–1.5cm caudad to the initial port, followed
by insertion of a standard length (100mm) 12mm Xcel
trocar (Ethicon) at the most caudal aspect of the incision,
another 1.0–1.5cm caudad to the prior low proﬁle port. We
minimized the intracorporeal proﬁle of the Xcel trocars, and
that in conjunction with the variety of trocar lengths allowed
us to stagger the external proﬁles in order to minimize
instrument clashing (Figure 2).
Tissue dissection is largely performed with standard
extralong laparoscopic instruments (nonlocking laparo-
scopic deBakey bowel forceps, right angle dissector, Mary-
land dissector, endoshears) and 5mm harmonic ACE 36cm
curvedshears(Ethicon).Utilizationofextralonginstruments
creates extracorporeal triangulation which compensates for
theintracorporealtriangulationaﬀordedbyspacedtrocarsin
multisite laparoscopy. Following takedown of the white line
of Toldt, the 0 degree laparoscope is exchanged for a 5mm,
45cm, and 30degree laparoscope with a right angle adaptor
and inline camera head (Strkyer).
LESS-RN recapitulates standard LRN technique [3]. This
includes incision of the descending colonic attachments to
the abdominal sidewall along the white line of Toldt down
to the level of the iliac vessels with subsequent medial-
visceral rotation of the colon to expose the ureter and
underling kidney. The ureter is identiﬁed, clipped, and cut
using 5mm Ligamax Clip applier (Ethicon) and endoshears.Diagnostic and Therapeutic Endoscopy 3
Table 1: Demographics, Tumor Characteristics, Perioperative Variables, and Outcomes.
LESS-RN (n = 6) LESS-PN (n = 4) P value
Demographics
Age 58.7 58.8 .991
Sex (Male/Female) 2/4 1/3 .806
BMI (Kg/m2) 24.9 30.1 .073
Tumor size/location
Tumor Size (cm) 5.3 1.7 .045
Tumor Location
Upper/Mid/Lower Pole 2/2/2 1/2/1
Renal Vein Thrombus 2 0
Perioperative Variables
Operative Time (minutes) 150.8 177.0 .162
Estimated Blood Loss (mL) 112.5 133.3 .679
Warm Ischemia Time (minutes) n/a 22
Incision size (cm) 4.6 4.1 .143
Narcotic Requirement (yes/no) 3/3 2/2 1.000
Hospital Stay (hours) 54.4 80.3 .048
Outcomes/Complications
Conversion to open 0/6 (0%) 1/4 (25%) .241
Negative Margins 6 4 1.000
Malignant Histology 5 2 .312
Blood Transfusion 0 0 1.000
Complications 1 0 .241
Overall Survival 6 4 1.000
Figure3:Ligationofrightrenalveinwiththe45mmEndopathETS
Flex Articulating Linear Cutter.
The cut proximal ureter is then used for retraction allowing
safe access to the renal hilum, and the renal artery and
vein are individually dissected. Through the 12mm port
the Endopath ETS Flex 45 Endoscopic Articulating Linear
Cutter, with a white vascular reload (Ethicon), is used to
ligate and incise the renal artery followed by the renal vein
(Figure 3). In the case of an upper pole or locally advanced
mass, the adrenal gland is then taken en bloc with the kidney
and the remaining superior and lateral renal attachments
are freed utilizing the harmonic scalpel, and in the case of
a lower- or mid-pole mass, the adrenal gland is dropped
away from the kidney (after ligation on the main adrenal
vein on the left with the stapler and/or harmonic scalpel; or
on the right after separation from the kidney utilizing the
harmonicscalpelorEndovascularstapler).The12mmtrocar
is then exchanged for a 15mm Xcel bladeless trocar and the
specimen is placed in a 15mm Endo Catch specimen pouch
(Covidien, Mansﬁeld, MA) and intact specimen extraction is
made by extending the fascial opening between trocars.
2.3. Surgical Technique for LESS-PN with Ischemic Technique.
Initial surgical steps including positioning, single-site inci-
sion, pneumoperitoneum/trocar placement, colonic mobi-
lization, and ureteral identiﬁcation and vascular dissection
are identical to LESS-RN. The standard techniques of LPN
are recapitulated with few modiﬁcations [12]. Following
hilar control and tumor identiﬁcation, Gerota’s fascia is
incised down to the renal capsule, preserving fat overlying
the tumor. Subsequently, argon beam coagulator (ABC,
Conmed, Centennial, CO) is used to circumscribe the renal
capsule while leaving a healthy margin around the tumor.
Renal hilar occlusion is obtained by placing laparoscopic
vascular bulldog clamps (Aesculap, Center Valley, PA) on
the renal artery and vein. Cold shears are then used to
excise the lesion, making certain to leave a margin of healthy
tissue around the specimen. Hemostasis is then achieved,
ﬁrst using ABC over the resected tumor bed. Next ﬂoseal
(Baxter, Deerﬁeld, IL) is placed in renal defect, followed by
a surgicel bolster (Ethicon, Somerville NJ) and then sutured4 Diagnostic and Therapeutic Endoscopy
Figure 4:6monthpostoperativeimageofsurgicalincisionofLESS-
PN.
renorrhaphy [13]w i t h3 - 0v i c r y ls u t u r e so na nS Hn e e d l e
are precut 10cm long with a Lapra-Ty clip (Ethicon) on
the free end. Simple interrupted sutures are placed in the
renal defect with second Lapra-Ty clip on the distal end.
Bioglue (albumin-glutaraldehyde sealant-adhesive, Cryolife,
Kennesaw, GA) is then placed to seal the renorrhaphy [14]
and then the laparoscopic bulldogs are removed, and the
renorrhaphy is inspected for bleeding. The specimen is then
extracted through a 5mm Endo Catch specimen pouch in a
similar fashion to the LESS-RN.
2.4. Surgical Technique for Nonischemic LESS-PN. In one
case, the Habib 4X (Angiodynamics, Queensbury, NY), a
bipolar laparoscopic radiofrequency ablation device, was
utilized to achieve a zone of parenchymal hemostasis in the
absence of ischemic renal conditions prior to cold tumor
excision and renorrhaphy, as described above [15, 16].
2.5. Postoperative Management and Followup. Postopera-
tivelythepatientswerestartedonKetorolacandtramadolfor
pain.Narcoticswerenotgivenunlessrequestedbythepatient
for breakthrough pain. Patients were given clear liquids on
the same day of surgery and were then advanced as tolerated.
CBC and SMA-7 were monitored postoperatively on daily
basis. Patients were discharged on tramadol pro re- nata,
and seen in the outpatient clinic within 1-2 weeks. Followup
exam (Figure 4), laboratory and QoL determination, and
imaging studies were obtained as per protocol depending on
tumor pathology.
2.6. Data Collection and Analysis. Data were prospec-
tively collected from the consent at the ﬁrst clinic visit.
Demographic factors [age, race, sex, BMI (Kg/m2), disease
characteristics (tumor size, clinical and pathological stage,
tumor pathology) perioperative variables [Operative time
(minutes), EBL, incision size (cm), margin status, narcotic
requirement (if any), time to advancement to regular diet
(days)andlengthofhospitalstay(days),andcomplications],
quality of life- (QoL-) related outcomes [visual analog pain
(VAP) score at discharge and 6 months postoperatively; time
to return to normal activities (days), and SF-36 health survey
(SF-36 V. 2.0; Medical Outcomes Trust, Inc., Boston, MA)],
and disease outcomes (overall- and disease-speciﬁc survival)
were recorded and analyzed for this initial cohort. Data was
analyzed between the two groups (LESS-RN and LESS-PN)
utilizing Student’s t-test and Fisher’s exact test, and for QoL
and pain scores utilizing single-factor ANOVA with P<. 05
is considered signiﬁcant.
3. Results
Demographics, tumor characteristics, perioperative vari-
ables, and outcomes and complications for the LESS-RN and
LESS-PN groups are summarized in the table. Mean age for
the entire cohort was 58.7 ± 11.0y e a r s( 5 8 .8 ± 5.9y e a r s
for LESS-PN, 58.7 ± 13.8 years for LESS-RN, P = .991)
mean BMI was 27.0 ± 4.6Kg/m 2. Median followup was 9.8
months (range 8–12 months). Six lesions were in the left
kidney and four were in the right; four tumors were in the
mid pole, 3 in the upper pole, and 3 in the lower pole
of the kidney. Two tumors had renal vein thrombi, one of
which also had metastatic disease. Median tumor size on
ﬁnal histopathologic analysis for the LESS-RN group was 5.0
(range, 2.3–9) cm, and for the LESS-PN was 1.7 (range, 1.4–
2) cm (P = .045).
LESS-RN was successfully performed on all 6 patients
without conversion to multi-site laparoscopic or open
surgery; two of these included successful enbloc resection
of the renal vein thrombus, and one of which was also
a cytoreductive nephrectomy. LESS-PN was successfully
performed on 3 of four attempts with one conversion to
open PN due to failure to progress, due to the patient’s
prior history of prior intraabdominal surgery and radiation.
No signiﬁcant diﬀerences were noted between the LESS-RN
and LESS-PN groups with respect to perioperative variables:
Mean operative time (LESS-RN 150.8 ± 27.6 versus LESS-
PN 177 ± 24.1m i n u t e s ,P = .162), mean estimated blood
loss (LESS-RN 133.3±75.3 versus LESS-PN 112.5±75.0mL,
P = .679), and mean incision size (LESS-RN 4.6 ±0.5v e r s u s
LESS-PN 4.1 ± 0.3cm,P = .143). The median hospital stay
was signiﬁcantly longer in LESS-PN (80 hours; range 73–88)
compared to LESS-RN (52 hours; range 29–86, P = .048).
Median warm ischemia time (for 3 tumors performed with
ischemic technique) was 24 minutes (range 19–26).
Histology revealed RCC in the majority of resected
lesions, 5/6 (83%) LESS-RN and 2/4 (50%) LESS-PN. Of the
seven patients with RCC, clear cell was the most common
tumor (71%), one patient had a cystic RCC (14.3%) and
one had a chromophobe RCC (14.3%). Three benign lesions
were resected, two lipid poor angiomyolipomas and one
oncocytoma. All patients had negative resection margins.
6-month postoperatively patients who underwent LESS-PN
had excellent preservation of overall renal function with
mean preoperative/postoperative values for serum creatinine
(0.7 ± 0.1v e r s u s0 .8 ± 0.2mg/dL,P = .194) and estimated
Glomerular Filtration Rate (99.3 ± 10.9v e r s u s8 6 .8 ±
29.2mL/min/1.73m2, P = .419).
One half the patients (overall and in each group)
did not require further opiate supplementation of theirDiagnostic and Therapeutic Endoscopy 5
postoperative analgesics. Mean VAP score at discharge, 1
month postoperative, 3 months postoperative, and 6 months
postoperative was: 1.3±1.3,0.9±0.7,0.5±0.9, and 0.4±0.9,
resp., P = .204). Mean preoperative, 1 month postoperative,
3 month postoperative, and 6 month postoperative SF-36
QoL Score was: 73.8 ± 10.4,67.7 ± 10.8,74.4 ± 10.4, and
77.1 ± 8.9, resp., P = .222). Mean time to return to normal
nonstrenuous activity was 6.6 ± 2.9 days (median 6, range
3–12).
No patients required blood transfusions. One patient
(10%) had a complication, a pneumothorax which was
treated with tube thoracostomy decompression with reso-
lution and tube removal within 23 hours. All patients are
currently alive, and there has not been any evidence of
radiographic progression in any of the patients with RCC.
4. Discussion
LESS is an emerging surgical technique which may promise
further reductions in morbidity and improved cosmesis for
patients.EmergingdataonLESShasbeenreportedingeneral
surgical,gynecologic,andurologicprocedures[17–22].LESS
for renal surgery was ﬁrst reported in 2007 and since then
a handful of authors have described variations of their
technique in order to perform both RN and more recently
PN for a variety of indications [10, 11, 23–25]. This report
represents the ﬁrst report in the literature of LESS-RN with
renal vein thrombectomy and cytoreductive nephrectomy
and the second group to report LESS-PN in adults. As such,
this report further corroborates (partial nephrectomy) and
demonstrates (renal vein thrombectomy) that increasingly
complex procedures can be safely performed with the LESS
platform.
In order for LESS to become a viable alternative to
traditional multi-site laparoscopy, it must ﬁrst be proven
to be feasible, safe, and reproducible and with equivalent
outcomes. While there are few reported cases of LESS
procedures, the existing data has demonstrated impressive
initial outcomes comparable to traditional laparoscopy [26].
This is consistent with our experience; nine of ten cases
were completed without the need for conversion to open
or traditional laparoscopic technique, OR times to complete
thesewere(meantotalcohort)161minutes,EBLwas125mL
and no patients required blood transfusions. This is compa-
rable to existing large multi-site series which demonstrate
means of 105–201 minutes OR time, 172–300cc EBL and
4.5% transfusion rates [4, 5, 8]. All patients had negative
margins, and patients who underwent LESS-PN had mean
WIT under 30 minutes, without signiﬁcant changes in crea-
tinine and eGFR, consistent with excellent short-term renal
preservation. While the numbers are small, this is certainly
also comparable to a large multi-institutional series of multi-
site LPN which demonstrated a mean warm ischemia time of
30.7minutes, and preoperative and postoperative creatinine
of 1.01 and 1.18 mg/dL, respectively [8]. Complications rate
was reasonable with only one patent having a signiﬁcant
complication despite the complexity and novelty of these
procedures.Assurgeons,ORstaﬀ,andtechnologiesimprove,
we only anticipate these outcomes to improve further.
Once LESS has overcome the initial threshold and found
to be comparable to the existing laparoscopic standard, it
must oﬀer a signiﬁcant advantage for surgeons and patients
to invest in this emerging technique. LESS allows RN and
PN to be performed with fewer incisions as compared with
traditional laparoscopic technique. The average incision size
in this series was 4.42cm with no need for any additional
incisions. In addition to excellent postoperative cosmesis
(Figure 4)a ﬀorded by substitution of multiple trocar sites in
traditional laparoscopy by often almost imperceptible scars
in the umbilical region, signiﬁcant QoL beneﬁts may be
attained by minimization of abdominal incision. Prior work
has demonstrated that decreasing incision size or specimen
morcellation may decrease postoperative discomfort [6, 27].
However, while morcellation of renal masses may allow for
reduction of incision size, it also results in distortion of renal
architecture which may compromise accurate staging and
grading of RCC [28] .T h u sa l lL E S Sp r o c e d u r e sw e r ep e r -
formed adhering to fundamental oncologic principles and
tumors were extracted using intact specimen entrapment
bags to prevent tumor seeding to the single incision site [29].
Consolidationofworkingtrocarsandtheextractioninci-
sion into one site may result in reduced incisional morbidity
as evidenced by limited need for narcotic medications in this
series (Table 1). More than half of the patients in this cohort
did not require any narcotic supplementation and of those
that did, most did so for less than 24 hours postoperatively.
This may in part be due to our pathway which places patients
on Ketorolac immediately post operatively [30, 31]. The
resultant beneﬁts of this are translated into preserved quality
of life as evidenced by low discharge mean visual analog pain
score (1.3), returning to normal nonstrenuous activity in
less than one week, the lack of signiﬁcant diﬀerence between
preoperative and postoperative SF-36 scores (P = .222).
Since LESS procedures are relatively new and in evolu-
tion, many techniques have been described but no widely
accepted standard exists. LESS has gained recent interest,
and this has lead surgeons to use traditional tools in
unique ways as well as encouraging industry to develop
a variety of novel platforms and innovative instruments
to ease the learning curve and facilitate these procedures.
The gelport laparoscopic system (Applied Medical, Rancho
Santa Margarita, CA) [11] is a laparoscopic hand port which
allows introduction of multiple trocars while maintaining
an airtight seal. Specialty designed single-port laparoscopic
systems such as the Uni-X (Pnavel Systems, Morganville,
NJ) [32], R-port (Advanced Surgical Concepts, Dublin,
Ireland)[10,23,24],andtheSILSport(Covidien,Mansﬁeld,
MA) are essentially multiple ﬁxed trocar ports that are
inserted through modiﬁed Hasson technique. We believe
that our technique of using multiple traditional and low-
proﬁle trocars placed through a single incision oﬀers some
signiﬁcant advantages. Both the gelport and the specially
designed multisite trocars add additional cost to the proce-
dure. Furthermore, specially designed multisite ports have
ﬁxed positions which limit separation of the trocars and
prevent the use of additional trocars. In 3 cases we added a
4th trocar in the most caudal aspect of the incision, a 12mm
trocar allowed for the insertion of an Endo Paddle retract6 Diagnostic and Therapeutic Endoscopy
(Covidien), a retractor used for bowel retraction used for 2
patients with renal vein thrombi and one large upper pole
renal mass. While some have suggested that the drawback
of our method of LESS is the “swiss cheese” defect and
weakening of the fascia, but we have not found this to be the
case [33].
Triangulation is the primary underlying technical prin-
ciple in laparoscopy and the greatest hurdle to overcome
in LESS. Proximity of the working ports through the single
incisions limits achievable separation which is necessary for
triangulation. A variety of novel trocars, ports, and instru-
ments have been developed speciﬁcally for or adapted for
LESS. While we enthusiastically encourage the development
of such products and believe that these will improve the
technical feasibility of these surgeries our initial experience
has been performed without the use of any such specialized
tools. We believe that the beneﬁts of using conventional
laparoscopic trocars and instruments are primarily two
fold: (1) surgeon familiarity and comfort, (2) cost savings
[minimizing the use of ﬂexible/articulating instruments
which are disposable]. Given that our OR times, and other
outcomes are consistent with those of large published series
of multiport RN and LPN [4, 5, 8], we feel that our approach
of utilizing conventional laparoscopic instruments facilitates
surgeoncomfortandsafeadoptionoftheLESSplatformwith
excellent results.
We believe that our utilization of extra-long laparoscopic
instruments and cameras creates a zone of extracorporeal
triangulation which, when applied through a peri-umbilical
incision which is close to the kidney, creates suﬃcient
working freedom and attenuates clashing. Furthermore, our
utilization of staggered trocars of lengths and a right-angled
camera further minimizes instrument clashing and allowed
greater angulation of laparoscopic handles. Thus we have
demonstratedtheLESSrenalsurgerycanbeperformedusing
essentially the same tools that might be used to perform
traditional multisite laparoscopy. Articulating instruments,
trocars that allow the insertion of bent instruments and
ﬂexible laparoscopes all may provide further methods of
overcoming these challenges and are in the process of being
further evaluated by our group.
Despite advances in LESS considerable challenges
remain. The upper posterior pole of the kidney is the most
diﬃcult portion of the renal dissection. Even with the use
of bariatric laparoscopic instruments this region is diﬃcult
to reach because of the greater working distance from the
umbilicus, and “turning the corner” or getting over the
upper pole to the posterior aspect of the kidney can be
demanding with rigid instruments that do not articulate.
Additionally retraction of the bowel and liver without
multisite laparoscopy is challenging. While future advances
in laparoscopes, trocars, and instruments may overcome
these technical considerations, novices to LESS renal surgery
may consider extra caution in attempting these procedures
in patients with greater BMIs and patients with bulky upper
pole posterior lesions. Particular consideration must be
employed when attempting LESS-PN; while intracorporeal
suturing is feasible for obtaining hemostasis and closure of
therenalcollectingsystemandparenchyma,tumorsthatmay
not be easily accessible from the umbilicus due to distance
(such as posterior, upper pole lesions) may present further
diﬃculties and present onerous limitation on being able
to deploy laparoscopic needle drivers at a suﬃcient angle.
Indeed, development and reﬁnement of robotically-assisted
LESS may allow a greater degree of freedom and surmount
such diﬃculties.
Increased detection of small renal masses has required
urologist to gain familiarity with procedures that ensure
adequate oncologic control while preserving renal function
[34]. LESS-PN allows for extraction of the enhancing
renal lesion, deﬁnitive histologic conﬁrmation with excel-
lent preservation of renal function in this series. In a
recent publication, Kaouk and Goel utilized a nonischemic
technique to perform LESS-PN. After PN these authors
achieved hemostasis using ABC, Surgicel and a variety
of surgical adhesives, however due to inability to achieve
adequate hemostasis in one case they had to convert to
multiport laparoscopy [25]. We attempted a nonischemic
technique in one case, utilizing the Habib 4X laparoscopic
radiofrequencyresectiondevice,whicheasilyﬁtsthroughthe
12mm laparoscopic port. This device allows excision of the
renal mass while maintaining hemostasis by ablating normal
renalparenchymaandcreatinganavascularplanearoundthe
tumor allowing excision of the mass with minimal blood loss
and preserving histologic integrity of the specimen [16].
Despite the novelty of these procedures we rapidly
adopted an excellent comfort level for performing complex
LESS-RN. Two patients had renal tumors greater then 7cm,
both with renal vein thrombi. One of these patients had
widely metastatic disease and elected to undergo cytore-
ductive LESS-RN. Traditional laparoscopic cytoreductive
nephrectomy has been demonstrated to have favorable
morbidity when compared with open technique and thus we
performed to our knowledge the ﬁrst reported LESS cytore-
ductive nephrectomy [35]. The patient did well and was able
to resume targeted biologic therapy on postoperative day 14.
Thelimitednumberofproceduresandthelackofadirect
comparison to traditional multi-site LRN and LPN limit
our ﬁndings. However, this preliminary prospective series
demonstrates that LESS-RN, renal vein thrombectomy, and
PN is safe and technically feasible method for performing
complex renal surgery while maintaining strict adherence to
oncologic principles, with excellent preservation of quality
of life, low discharge pain scores, and cosmetic beneﬁt.
Our encouraging pilot results have led to a prospective
comparison between LESSand multiport laparoscopy, which
we hope will delineate what, if any speciﬁc advantages, may
lie with the LESS approach.
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